Should you be cautious about the hype surrounding tech stocks?

Published 04-SEP-2020 13:10 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Following the COVID-19 meltdown on the Australian stock market, a new generation of investors who were stuck at home, hit the market attempting to create some cashflow.

Primarily, their focus has been on technology stocks, so much so, that over the past few months talk around these stocks has accelerated at lightning speed. In order to understand the hype around these stocks, we need to take a closer look at the technology sector in Australia and the US.

In Australia, the sector is quite small in relation to our overall market given there is not one technology company listed in the top 50 on the All Ordinaries Index. While in the US, technology stocks make up a significant share of the S&P 500 given that the top six technology companies make up around 17 per cent of the total market capitalisation of the Index.

To understand why Australians are so excited about technology stocks, however, we need to look at the NASDAQ, which is heavily weighted to technology companies. Since 1971, the NASDAQ has grown at a rate 0.65 points per day to the end of August in comparison to Dow Jones, which over the same period grew two times faster at a rate of 1.61 points per day. That said, in the 1970s technology was just getting started, so we need to look at more recent times to really gauge what is occurring.

Prior to the GFC, the NASDAQ rose from October 2002 to the GFC high in November 2007 at a rate of 0.97 points per day. In the first 12 months following the GFC crash, it rose from March 2009 to April 2010 at a rate of 3.06 points per day.

Now let’s compare that to what occurred recently in the run up prior to the COVID-19 crash. Between December 2018 and February 2020, the NASDAQ has been rising at 8.69 points per day, while over the past five months, from the low in March 2020 to the end of August, it has been rising at 33.09 points per day or 281 per cent faster.

Why has this occurred?

The faster a stock or market is moving, the more interest it generates from investors who jump in attempting to cash in for fear of missing out. The concern with this is that Australian investors are assuming that technology stocks in Australia will perform like their US counterparts.

However, this is not the case given that the Technology Sector has risen less than 1 point per day over the past couple of years, which signifies that there is not a lot of support for these companies from the big end of town.

Unfortunately, there is an expectation from investors that this stellar rise in the US will continue forever, but the steepest rise on a market or stock is just before it starts to fall away. Given the steep rise on the NASDAQ right now, investors would be wise to be very careful when it comes to investing in technology stocks.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X